An interventional study of Pulp therapy and Sodiumhexametaphosphate in Pulp Disease, Dental, sponsored by Minia University. Status unknown. Open to participants aged 4 Years to 10 Years. Per ClinicalTrials.gov, last updated 2023-12-14.
Sponsored by Minia University · Not applicable, Interventional, and Treatment
Sodiumhexametaphosphate will be tested as pulp capping material in comparison to MTA for primary teeth pulp therapy
129 studies on the registry are indexed under Dental Pulp Diseases; 39 are open to participants now.
This study's planned enrollment of 100 is above the median of 50 across 107 interventional studies indexed under Dental Pulp Diseases.
Browse Dental Pulp Diseases studies →Minia University is the lead sponsor of 369 studies on the registry; 117 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Pulp therapy · Drug: Sodiumhexametaphosphate
Other: Pulp therapy · Other: MTA
Pulp capping material
Sodiumhexametaphosphate
MTA
Clinical success
Absence of pain, swelling and sinus tract
Time frame: One year
Radiographic success
Absence of periapical lesions, internal or external root resorption
Time frame: One year
No study locations are listed for this record.
This study is status unknown, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.